Form 4 for MXCT MAXCYTE, INC.
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0001209191-23-001980 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-05 | 2023-01-03+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.98 | +29.1K | 9,467 | New | +$28.6K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.08 | -29.1K | 0 | -100% | -$148.1K |
| DM | 2023-01-05 | 2023-01-03+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.00 | -29.1K | 2,468 | -92% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | M | A | 10,513 | $0.98 | 10,513 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-03 | S | D | 10,513 | $5.13 | 0 | D | — | — | (F2) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 3 | Common | Common Stock | 2023-01-04 | M | A | 9,153 | $0.98 | 9,153 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-04 | S | D | 9,153 | $5.07 | 0 | D | — | — | (F3) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 5 | Common | Common Stock | 2023-01-05 | M | A | 9,467 | $0.98 | 9,467 | D | — | — | |
| 6 | Common | Common Stock | 2023-01-05 | S | D | 9,467 | $5.04 | 0 | D | — | — | (F4) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-01-03 | M | D | 10,513 | $0.00 | 21,088 | D | $0.98 · — to 2026-06-13 | 10,513 Common Stock | (F5) This option is fully vested and exercisable. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | M | D | 9,153 | $0.00 | 11,935 | D | $0.98 · — to 2026-06-13 | 9,153 Common Stock | (F5) This option is fully vested and exercisable. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2023-01-05 | M | D | 9,467 | $0.00 | 2,468 | D | $0.98 · — to 2026-06-13 | 9,467 Common Stock | (F5) This option is fully vested and exercisable. |